A new tool is helping surgeons at AdventHealth transform lung cancer surgery and help save more lives. Cytalux is a fluorescent dye that lights up cancer cells during surgery. As the first hospital in Florida and the second in the U.S. to use this groundbreaking technology, AdventHealth is providing faster, more accurate treatment for patients.
“This new advancement helps patients by reducing the need for secondary surgeries and minimizing operating room time,” explains Dr. Colleen Gaughan, thoracic surgeon at the AdventHealth Heart, Lung and Vascular Institute.
Cytalux is administered as an IV medication before surgery and circulates through the patient’s body during the procedure.
“It gets taken up by the tumor and then during surgery, while (the patient is) already asleep, we use our special near-infrared camera to then see the (cancerous) tumor glowing in real time,” Gaughan recently told Yahoo News. She added that it helps surgeons pinpoint affected areas with more precision.
“Before this was available to us, we had to rely on CT scans or invasive techniques like injecting dye or placing wires into the tumor,” Gaughan told the CancerNetwork. “These older methods added time and expense to the procedure.”
This innovation has already saved lives, including Reena Caprario, who was diagnosed with stage one lung cancer last year.
“My lymph nodes under my armpits were hurting. I thought, this isn’t normal,” Caprario said. After her surgery with Dr. Gaughan, she has been cancer-free for over a year. Caprario is one of more than 40 patients who have benefitted from using Cytalux during surgery at AdventHealth Celebration.
“They (patients) experience little to no side effects. The most common side effects are itching or nausea,” Gaughan told Becker’s Healthcare podcast.
Dr. Gaughan credits early detection, advanced technology, and her dedicated team for these life-changing results. She urges high-risk individuals to get screened annually.
“If you know that something is wrong, don’t blow it off,” Caprario advises during a recent WFTV News interview.
Local leaders, officials, and construction workers gathered today to commemorate a major milestone in the expansion underway at AdventHealth Daytona Beach: placing the final steel beam.
Dr. Jeffrey Keen, a board-certified orthopedic surgeon specializing in adult reconstruction, orthopedic surgery, robotic-assisted surgery, and sports medicine, has returned to AdventHealth Medical...
In recognition of National Donate Life Month, nearly 300 transplant patients and their families enjoyed AdventHealth’s 2025 transplant reunion.
By managing ASCs as distinct entities with tailored operations, financial structures, and physician partnerships, the East Florida Division is fostering collaboration, efficiency, and growth.
According to the National Kidney Foundation, more than 101,000 people are currently on the organ transplant list in need of a new kidney. However, only about 17,000 transplants happen each year —...
The AdventHealth Board of Directors has appointed David Banks as the organization’s new president/CEO, effective immediately.
Ming Wu, MD -- a family medicine doctor with AdventHealth Littleton -- talks about the ways to lessen the impact of seasonal allergies this spring.
The East Florida Division is forming strong partnerships with independent physicians, driving mutual success and improving hospital throughput.
